Jonathan Wolf

Jonathan Wolf is a prominent figure in the health technology industry, serving as the co-founder of ZOE, a company that leverages personalized tests, AI, and an extensive nutritional study to educate individuals about their body's response to food.

He also played a key role in establishing ZOE's COVID Symptom Study, which has grown to become the largest study of COVID globally, with over 4 million participants, now supported by the UK government. The study offers real-time monitoring of COVID cases, aids vaccine trials, and conducts vital scientific research in collaboration with King's College London.

Before his endeavors at ZOE, Jonathan excelled as the Chief Product Officer at Criteo. Joining the startup with 30 employees, he played a pivotal role in its transformation into a publicly traded company on NASDAQ with over 2,000 employees and a revenue exceeding $1 billion. During his seven-year tenure, Jonathan spearheaded the growth of the product organization, established sales operations, and set up Criteo's New York office.

Jonathan Wolf's academic journey is equally impressive, having been recognized at prestigious institutions like Oxford University and Harvard. While at Oxford, he earned the coveted Gibbs prize for Physics and presided over the esteemed Oxford Union. His educational background includes studies in Philosophy, Economics at Harvard University, and a Master's degree in Physics from the University of Oxford, where he clinched the Gibbs prize for the top BA in Physics. He has been honored as a Foundation Fellow at Corpus Christi College, Oxford, since 2015.